Page title
Search SAMHSA Publications and Digital Products
Store Facets Summary
Main page content
Displaying results 1 - 10 of 78
Opioid-Overdose Reduction Continuum of Care Approach (ORCCA) Practice Guide 2023
Published: September 2023
This guide was drawn from HEALing Communities Study (HCS) learnings to-date and expert insights to provide guidance regarding implementation of ORCCA menu strategies.
National Center on Substance Abuse and Child Welfare Resources for Professionals Working with Pregnant and Parenting People Affected by Substance Use Disorders and Involved with Child Welfare
Published: August 2023
The third supplemental to SAMHSA’s Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants publication. A compendium of resources for professionals who work with parents involved with child welfare.
Preparing For Your Baby: Information for Pregnant People with Substance Use Disorders
Published: August 2023
The fourth supplemental resource to SAMHSA’s Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants publication. This document contains information for pregnant people with a substance use disorder and preparing to deliver.
Working with Child Protective Services to Support Pregnant and Parenting People, Their Infants, and Families Affected by Substance Use Disorders: A Factsheet for Health Care Providers
Published: August 2023
This document accompanies the Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants publication. It offers information about child welfare systems and what the health care provider's role is in developing a Plan of Safe Care.
Resources for Professionals Working with Pregnant and Parenting People Affected by Substance Use Disorders
Published: August 2023
The second supplemental to SAMHSA’s Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants publication. This document contains information for pregnant people with a substance use disorder and professionals who provide services for them.
Digital Therapeutics for Management and Treatment in Behavioral Health
Published: July 2023
This advisory introduces readers to digital therapeutics (DTx) and the benefits of their use in behavioral health. It describes the research, regulatory, and reimbursement implications for DTx as well as selection and implementation considerations.
Advisory: Evidence-Based, Whole Person Care of Pregnant People Who Have Opioid Use Disorder
Published: May 2023
This Advisory outlines how healthcare providers (i.e., obstetrician-gynecologists [OB-GYNs], primary care physicians, and other professionals who treat pregnant people) can take an active role in supporting the health of pregnant individuals who have OUD and their babies.
Practical Tools for Prescribing and Promoting Buprenorphine in Primary Care Settings
Published: December 2021
This resource provides information to primary care providers and practices on how to implement opioid use disorder treatment using buprenorphine. It identifies common barriers and strategies to overcome them. It documents step-by-step tactics to support buprenorphine implementation.
Treating Concurrent Substance Use Among Adults
Published: September 2021
This guide intends to educate clinicians and other stakeholders about the harms of using more than one substance and consideration for addressing concurrent substance use (CSU) and concurrent substance use disorders (CSUD).
TIP 63: Medications for Opioid Use Disorder - Executive Summary
Published: August 2021
The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.